TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants January 10, 1975
TCL Archive NCI to Implement Plan For Stepped Up Patient Accrual Despite Reservations OF Group Chairmen December 4, 1987
TCL Archive UPCC Wins $26 Million Center Grant From NCI; Massey Center Opens New Outpatient Clinic. October 20, 2000
